GLP-1 medications have become one of the biggest topics in weight loss. But with more people turning to these drugs to help ...

Health systems preparing Medicare GLP-1 Bridge program focus on staff education, prior authorization, and workflow coordination ahead of July 1 launch.

But Why is a show led by kids. They ask the questions and we find the answers. It’s a big interesting world out there. On But Why, we tackle topics large and small, about nature, words, even the end ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Courtney Schley Courtney Schley is deputy director of editorial operations and ...

June 29, 2026 Fish oil supplements successfully delivered omega-3s to the brain, but a two-year study found no meaningful benefits for memory, cognition, or Alzheimer’s-related brain changes. The ...

Hughes discusses managing GI toxicities and the need for research regarding GLP-1 use among breast cancer patients and survivors. As the clinical use of GLP-1 receptor agonists continues to rise, ...

FDA approves sacituzumab govitecan-hziy as monotherapy and with pembrolizumab for first-line treatment of advanced triple-negative breast cancer. On June 24, 2026, the Food and Drug Administration ...

We empower clinicians with the tools, training, and support to turn evidence into action. Our comprehensive EBP model offers user-friendly resources, expert-led education, and personalized ...

Summer is “Go” for launch, and NASA has a universe of ways to help you to jump in, explore, and create! Whether you prefer to spend this season fueling your creativity, going outdoors into nature, or ...

This is a fair market value price provided by Massive. Learn more.